Cargando…
Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode
Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction owing to the presence of anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies. A 77-year-old man with APAP was referred to our hospital for whole-lung lavage (WLL) due to oxygenation exacerb...
Autores principales: | Yanagisawa, Atsushi, Takimoto, Takayuki, Shintani, Ryota, Kobayashi, Takehiko, Hirose, Masaki, Arai, Toru, Inoue, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465295/ https://www.ncbi.nlm.nih.gov/pubmed/37164675 http://dx.doi.org/10.2169/internalmedicine.1592-23 |
Ejemplares similares
-
B cell‐activating factors in autoimmune pulmonary alveolar proteinosis
por: Hirose, Masaki, et al.
Publicado: (2021) -
Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study
por: Akasaka, Keiichi, et al.
Publicado: (2015) -
Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis
por: Sakaue, Saori, et al.
Publicado: (2021) -
Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis
por: Kinehara, Yuhei, et al.
Publicado: (2014) -
Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
por: Arai, Toru, et al.
Publicado: (2020)